A study of incidence of Australia antigen and derangements in liver function tests in leprosy.
The present study was conducted in 50 patients of various subtypes of leprosy (Lepromatous, Tuberculoid, Borderline borderline) and 25 healthy control, for detection of Australia antigen and various liver function tests (serum protein, cholesterol, alkaline phosphates, SGOT, SGPT, bilirubin and liver biopsy) to see incidence of Australia Antigen and derangement in liver function. It was concluded that incidence of Australia antigen in study and control group was zero. Total serum protein and serum globulin was increased in lepromatous leprosy. A/G ratio was reversed in 34.3% and 50% in lepromatous and tuberculoid leprosy respectively. Granulomatous hepatitis was seen in 66.66% and 50% cases of lepromatous and tuberculoid leprosy respectively. No relationships was established between hepatic lesion, Australia antigen and liver function test.
Nayak
K C
KC
Department of Medicine, S.P. Medical College, Bikaner.
Gupta
R K
RK
Aggarwal
T D
TD
Chadda
V S
VS
Kumar
K K
KK
D000293:Adolescent; D000328:Adult; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D015439:Leprosy, Borderline / Q000150:complications / Q000503:physiopathology*; D015440:Leprosy, Lepromatous / Q000150:complications / Q000503:physiopathology*; D015441:Leprosy, Tuberculoid / Q000150:complications / Q000503:physiopathology*; D008099:Liver / Q000473:pathology / Q000503:physiopathology*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged
D006514:Hepatitis B Surface Antigens